Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jed Lusthaus"'
Autor:
Sophia Zagora, Ezekiel J Kingston, Jed Lusthaus, Richard Symes, Pushpa Raman, Peter McCluskey
Publikováno v:
Journal of Glaucoma. 31:129-132
Purpose The purpose of this study was to report a case of infective necrotizing scleritis following XEN Gel Stent with mitomycin-C. Methods Case report. This is a case report of a 68-year-old woman. Results XEN Gel Stent glaucoma surgery enhanced wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::476f59e45eb07b2c27c5d827915363b3
https://doi.org/10.1097/ijg.0000000000001959
https://doi.org/10.1097/ijg.0000000000001959
The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma
Publikováno v:
Journal of Experimental Pharmacology. 12:539-548
Glaucoma causes irreversible vision loss, with elevated intraocular pressure (IOP) being the only known modifiable risk factor. There are a variety of medical and interventional options for lowering IOP; however, despite these treatments, glaucoma co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fee034891de87c82c738f43495b12f3
https://doi.org/10.2147/jep.s281187
https://doi.org/10.2147/jep.s281187
Publikováno v:
Ophthalmology. Glaucoma
Purpose Noninvasive, detailed measurement of the dynamics of human aqueous outflow is difficult to achieve with currently available clinical tools. We used hemoglobin video imaging (HVI) to develop a technique to image and quantify human aqueous outf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0480522e3184b01ac49f2bd9b3f1c628
https://doi.org/10.1016/j.ogla.2019.04.001
https://doi.org/10.1016/j.ogla.2019.04.001
Publikováno v:
Eye (Lond)
Recent advances in the medical and surgical management of open-angle glaucoma have increased the number of treatment options available. Several new intraocular pressure (IOP)-lowering treatments target the conventional aqueous outflow (AO) system. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d3fdd7e45c0708db675bad908ae2350
https://www.repository.cam.ac.uk/handle/1810/308863
https://www.repository.cam.ac.uk/handle/1810/308863
PRECIS: Hemoglobin Video Imaging (HVI) provides a noninvasive method to quantify aqueous outflow (AO) perioperatively. Trabecular bypass surgery (TBS) is able to improve, and in some cases re-establish, conventional AO. PURPOSE: The purpose of this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee2fbaa678b575ae8960b20328c90b1
https://www.repository.cam.ac.uk/handle/1810/308862
https://www.repository.cam.ac.uk/handle/1810/308862
Autor:
Ivan Goldberg, Jed Lusthaus
Publikováno v:
The Medical journal of Australia. 210(4)
Glaucoma is an irreversible progressive optic neuropathy, for which the major proven treatment is to lower the intraocular pressure (IOP). Five groups of IOP-lowering eye drops have varying mechanisms of action. Some drops, such as β-blockers and α
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeb21dc16dac50e703c90d7acce6f23f
https://pubmed.ncbi.nlm.nih.gov/30767238
https://pubmed.ncbi.nlm.nih.gov/30767238
Autor:
Jed Lusthaus, Ivan Goldberg
Publikováno v:
Expert Opinion on Investigational Drugs. 25:1201-1208
Introduction: Intraocular pressure (IOP) is the most significant modifiable risk factor to prevent onset or progression of glaucoma. Glaucoma prevalence continues to increase, emphasizing the need for improved ocular hypotensive treatment options. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e1dc75bab9241215e6b0f49c83ac8f1
https://doi.org/10.1080/13543784.2016.1223042
https://doi.org/10.1080/13543784.2016.1223042
Autor:
Jed Lusthaus, Ivan Goldberg
Publikováno v:
Expert Opinion on Emerging Drugs. 21:117-128
Commercially available prostaglandin analogues (PGAs) activate the prostaglandin F receptor (FP) reducing intraocular pressure (IOP), thereby stabilizing glaucomatous optic neuropathy. Poor adherence with eye drops and intolerance impact treatment su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::931f1afbbb9fc323216ddb15ed605408
https://doi.org/10.1517/14728214.2016.1151001
https://doi.org/10.1517/14728214.2016.1151001
Autor:
Jed Lusthaus, Ivan Goldberg
Publikováno v:
Expert opinion on drug safety. 16(9)
Brimonidine tartrate and brinzolamide eye drops are often used as third and fourth line treatment options to reduce intraocular pressure (IOP) in the management of glaucoma and ocular hypertension. Better tolerated, more effective topical agents requ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::603380bddfe12041779292bfd5b18a97
https://pubmed.ncbi.nlm.nih.gov/28656780
https://pubmed.ncbi.nlm.nih.gov/28656780
Autor:
Jed Lusthaus, Colin I Clement
Publikováno v:
Manual of Glaucoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::416c28aac1dd70107bc46d9741b8c39c
https://doi.org/10.5005/jp/books/12649_21
https://doi.org/10.5005/jp/books/12649_21